RELEASE: The Golden State Innovation Act Introduced
SACRAMENTO – The Golden State Innovation Act of 2021 (AB 593) has been introduced to fuel job growth and innovation through the restoration of the Research and Development (R&D) Tax Credit and Net Operating Loss (NOL) deduction for Life Sciences companies in California. AB 593 was introduced by Assemblymembers Cottie Petrie-Norris, Kevin Mullin, Tom Daly and Jacqui Irwin and is supported by a coalition of Life Science companies and patient-advocacy groups.